SR 4
The committee on HHS deferred the measure
REQUESTING THE AUDITOR TO ASSESS BOTH THE SOCIAL AND FINANCIAL EFFECTS OF PROPOSED MANDATED HEALTH INSURANCE COVERAGE FOR A PERCENTAGE OF THE COSTS OF INTRAVENOUS KETAMINE THERAPY TO TREAT DEPRESSION.
- Hawaii
- Senate
- Introduced Jan 30, 2025
- Session 2025
Official Bill Page
Loading official bill page…
This state’s bills aren’t available here
Hawaii’s legislature doesn’t allow its bill pages to be shown on other sites. You can read the full bill on the official page.
View on official siteLegislative Timeline
4 actions-
The committee on HHS deferred the measure.
-
The committee(s) on HHS has scheduled a public hearing on 03-24-25 1:05PM; Conference Room 225 & Videoconference.
-
Referred to HHS, WAM.
-
Offered.